1Packer M, Poole-Wilson PA, Armstrong PW, et al. Comparative effects of low and high does of angiotension-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure: ATLAS study group. Circulation, 1999,100:2312-2318.
2Nanas JN, Alexopoulos G, Anastasiou-Nana MI, et al. Outcome of patients with congestive heart failure treated with standard versus high doses of enalapril: a multicenter study: High Enalapril Dose study group. J Am Coll Cardiol, 2000,36:2690-2695.
3Tang WHW, Vagelos RH, Yee YG, et al. Neurohormonal and clinical responses to high-versus low-dose enalapril therapy in chronic heart failure. J Am Coll Cardiol,2002,39:70-78.
4CONSENSUS Trial Study Group. Effect of enalapril on mortality in severe congestive heart failure: results of the cooperative North Scandanavian enalapril survival study. N Engl J Med, 1987,316:1429-1435.
5Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med, 1996,334:1350-1355.
6Pitt B, Poole-Wilson PA, Segal R, et al. Effect of losartan comparaed with captopril on mortality in patients with symptomatic heart failure: randomized trial the Losartan Heart Failure Survival Study ELITE-Ⅱ. Lancet, 2000,355:1582-1587.
7Cohn JN. Improveing outcomes in congestive heart failure: Val-HeFT Valsartan in Heart Failure Trial. Cardiology, 1999,91(Suppl 1):19-22.
8Pfeffer MA, McMurray JJ, Velazquez EJ,et al. Valsartan, Captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med, 2003,349:1893-1906.
9Pitt B."Escape" of aldosterone production in patients with left ventricular dysfunction treated with an angiotension converting enzyme inhibitor: implications for therapy. Cardiovasc Drugs Ther, 1995,9:145-149.
10Pitt B, Zannad F,Remme WJ, et al. The effect of spironolactone on morbidity and mortility in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Eng J Med, 1999,341:709-717.
